Home | Cancers | Lung Cancer

Lung Cancer

Early recall rates decline after second round of lung cancer screening

Scientists at the German Cancer Research Center have published results from the “Lung Cancer Screening Intervention Trial” (LUSI): The early repeat scan ...

University collaboration for early detection of lung cancer

The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung ...

Long telomere length associated with increased lung cancer risk

Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk ... Full story

Overcoming why a new treatment is resisted by lung cancer

A promising agent for the treatment of cancer has so far had little effect on the most common lung tumours, but new research from The University of Manchester has suggested how this resistance might be overcome. ... Full story

Immune Cells Recruited to Support Lung Cancer Growth Could Offer New Drug Targets

Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers from Weill Cornell Medical College found in a new study. Their discovery sheds light on how tumors establish a microenvironment that enables them to flourish, and may offer an effective new target for anti-cancer drugs. ... Full story

Women’s lung cancer cases hit 20,000

Cases of lung cancer in women have reached 20,000 a year in the UK for the first time since records began, according to new Cancer Research UK statistics*. ... Full story

Comorbid Conditions Associated With Worse Lung Cancer Survival

PHILADELPHIA — Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure had a higher risk of death than lung cancer patients without comorbid conditions, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. ... Full story

Comorbid conditions hurt lung cancer survival rates

by Lauren Riley, American Association for Cancer Research and Tom O'Connor, UNMC public relations ... Full story

Wistar Scientists Discover “Highly Effective” New Biomarker for Lung Cancer

PHILADELPHIA—(June 3, 2015)—Survival rates for patients with lung cancer increase dramatically the earlier the disease is diagnosed, underscoring the need for effective biomarkers that can be used for detection. Now, scientists at The Wistar Institute have found a protein that circulates in the blood that appears to be more accurate at detecting non-small cell lung cancer (NSCLC) than currently available methods used for screening. ... Full story

Moffitt Cancer Center Researchers Report that MEDI4736 Combined with Tremelimumab Results in Acceptable Toxicity, Clinical Activity in Non-Small Cell Lung Cancer Patients

TAMPA, Fla. – Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 155 | displaying: 1 - 10